A cross-sectional study to investigate the effects of SGLT-2 inhibitors on insulin secretion and resistance showed improvement in β-cell function and a 21% (p = 0.008) reduction in insulin resistance [99]. This evidence concerns the gene SLC5A2 and Insulin resistance.